Kim Newcomer, Julie Clauer, Khadijah Ameen, Andrea Incudine, Amy Mulvey, Kathy Steinberg, Jeneth Aquino, Ashley Geiger, Scott Campbell, Ashley Calabrese, Mohamedtaki Tejani, Manish Shah
{"title":"Patient experiences and unmet needs in diagnosis and treatment of metastatic colorectal cancer: results of a US survey.","authors":"Kim Newcomer, Julie Clauer, Khadijah Ameen, Andrea Incudine, Amy Mulvey, Kathy Steinberg, Jeneth Aquino, Ashley Geiger, Scott Campbell, Ashley Calabrese, Mohamedtaki Tejani, Manish Shah","doi":"10.1080/14796694.2026.2695213","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Metastatic colorectal cancer (mCRC) can impact patients beyond their physical health. We conducted a survey to evaluate patient perspectives on care and treatment experience.</p><p><strong>Methods: </strong>The survey was conducted by The Harris Poll in the United States. Adults with mCRC were recruited via online panels and patient advocacy groups. Sampling precision was measured via a Bayesian credible interval; data were accurate to within 5.3% points (95% confidence level).</p><p><strong>Results: </strong>Of the 344 respondents, 46% identified as non-Hispanic White, 25% as non-Hispanic Black/African American, and 22% as Hispanic; the mean age was 56 years. Overall, 31% reported that their mCRC diagnosis was delayed, with 83% wishing more information had been provided by their health-care provider at diagnosis. Mental health resources were difficult to access for 53% of the respondents and 88% experienced financial impacts because of their mCRC diagnosis. Furthermore, 49% reported negative impacts from health inequities affecting their care. Overall, 67% of the respondents wished for more power in treatment decision-making.</p><p><strong>Conclusions: </strong>The survey highlights key unmet medical and non-medical patient needs in mCRC care. Access to informational resources, including for financial assistance, and a greater emphasis on shared treatment decision-making would help patients feel valued and improve their mCRC experience.</p>","PeriodicalId":12672,"journal":{"name":"Future oncology","volume":" ","pages":"2445-2456"},"PeriodicalIF":3.1000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685566/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14796694.2026.2695213","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Metastatic colorectal cancer (mCRC) can impact patients beyond their physical health. We conducted a survey to evaluate patient perspectives on care and treatment experience.
Methods: The survey was conducted by The Harris Poll in the United States. Adults with mCRC were recruited via online panels and patient advocacy groups. Sampling precision was measured via a Bayesian credible interval; data were accurate to within 5.3% points (95% confidence level).
Results: Of the 344 respondents, 46% identified as non-Hispanic White, 25% as non-Hispanic Black/African American, and 22% as Hispanic; the mean age was 56 years. Overall, 31% reported that their mCRC diagnosis was delayed, with 83% wishing more information had been provided by their health-care provider at diagnosis. Mental health resources were difficult to access for 53% of the respondents and 88% experienced financial impacts because of their mCRC diagnosis. Furthermore, 49% reported negative impacts from health inequities affecting their care. Overall, 67% of the respondents wished for more power in treatment decision-making.
Conclusions: The survey highlights key unmet medical and non-medical patient needs in mCRC care. Access to informational resources, including for financial assistance, and a greater emphasis on shared treatment decision-making would help patients feel valued and improve their mCRC experience.
期刊介绍:
Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community.
The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.